Fractyl Health Inc (GUTS)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · GUTS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 255.3% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
GUTS — workforce reduction
Dated 2026-10-22
Costs Associated with Exit or Disposal Activities. On October 21, 2026, Fractyl Health, Inc. (the “ Company ”) adopted a plan to sharpen its strategic focus on its Revita ® program in connection with a strategic reprioritization. As part of the plan, the Company will reduce its workforce by approximately 45% of the Company’s current headcount. The reduction in force is expected to be completed during the fourth quarter of 2026. The Company estimates that it will incur charges of approximately…
Why it matters: The company says its staff cuts will lower cash use and extend its runway into Q2 2027. The next reports can show whether that plan is taking hold.
Supportive ifA company report shows quarterly operating cash burn at or below $8 million by the end of Q2 2027.
Worry ifA company report shows quarterly operating cash burn above $8 million at the end of Q2 2027. Or it shows cash runway ending before Q2 2027.
Why it matters: The code is set to take effect before a possible U.S. launch. Updates on payment coverage can show whether clinics can bill for the procedure.
Watch forCode 1122T takes effect on January 1, 2027. The company reports that payers cover the Revita procedure.
Also watch forCode 1122T does not take effect on January 1, 2027, or the company reports that payers do not cover the procedure.
Why it matters: The 12-month results test whether Revita can help patients keep at least 5% of their weight loss. This is the study's second main test.
Watch forThe company reports that more than 50% of Revita patients kept at least 5% of their starting weight loss at 12 months.
Also watch forThe company reports that 50% or fewer of Revita patients kept at least 5% of their starting weight loss at 12 months.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$364 on $10,000 · ±3.6% | How much price usually moves either way. |
| Bad day | $974 loss on $10,000 · 9.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,691 loss on $10,000 · 96.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.